These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7689189)
21. Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis. Hendrickx DA; Koning N; Schuurman KG; van Strien ME; van Eden CG; Hamann J; Huitinga I J Neuropathol Exp Neurol; 2013 Feb; 72(2):106-18. PubMed ID: 23334594 [TBL] [Abstract][Full Text] [Related]
22. Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. Hill KE; Zollinger LV; Watt HE; Carlson NG; Rose JW J Neuroimmunol; 2004 Jun; 151(1-2):171-9. PubMed ID: 15145615 [TBL] [Abstract][Full Text] [Related]
24. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. Adams CW; Poston RN; Buk SJ J Neurol Sci; 1989 Sep; 92(2-3):291-306. PubMed ID: 2809622 [TBL] [Abstract][Full Text] [Related]
25. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Trebst C; Sørensen TL; Kivisäkk P; Cathcart MK; Hesselgesser J; Horuk R; Sellebjerg F; Lassmann H; Ransohoff RM Am J Pathol; 2001 Nov; 159(5):1701-10. PubMed ID: 11696431 [TBL] [Abstract][Full Text] [Related]
26. Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions. Laman JD; Visser L; Maassen CB; de Groot CJ; de Jong LA; 't Hart BA; van Meurs M; Schellekens MM J Neuroimmunol; 2001 Sep; 119(1):124-30. PubMed ID: 11525809 [TBL] [Abstract][Full Text] [Related]
27. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases. Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798 [TBL] [Abstract][Full Text] [Related]
28. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Gay FW; Drye TJ; Dick GW; Esiri MM Brain; 1997 Aug; 120 ( Pt 8)():1461-83. PubMed ID: 9278635 [TBL] [Abstract][Full Text] [Related]
29. [Some aspects of histopathology in multiple sclerosis]. Kuhlmann T; Brück W Rev Neurol; 2000 Jun 16-30; 30(12):1208-12. PubMed ID: 10935252 [TBL] [Abstract][Full Text] [Related]
30. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls. Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969 [TBL] [Abstract][Full Text] [Related]
31. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Wolswijk G Brain; 2002 Feb; 125(Pt 2):338-49. PubMed ID: 11844734 [TBL] [Abstract][Full Text] [Related]
32. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253 [TBL] [Abstract][Full Text] [Related]
33. Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model. Imai M; Watanabe M; Suyama K; Osada T; Sakai D; Kawada H; Matsumae M; Mochida J J Neurosurg Spine; 2008 Jan; 8(1):58-66. PubMed ID: 18173348 [TBL] [Abstract][Full Text] [Related]
34. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord. Church JS; Milich LM; Lerch JK; Popovich PG; McTigue DM Glia; 2017 Jun; 65(6):883-899. PubMed ID: 28251686 [TBL] [Abstract][Full Text] [Related]
35. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of the hyaluronate receptor CD44 in canine distemper demyelinated plaques. Alldinger S; Fonfara S; Kremmer E; Baumgärtner W Acta Neuropathol; 2000 Feb; 99(2):138-46. PubMed ID: 10672320 [TBL] [Abstract][Full Text] [Related]
37. Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members. Fredrikson S; Söderström M; Hillert J; Sun JB; Käll TB; Link H Acta Neurol Scand; 1994 Mar; 89(3):184-9. PubMed ID: 7518178 [TBL] [Abstract][Full Text] [Related]
38. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. Ulvestad E; Williams K; Mørk S; Antel J; Nyland H J Neuropathol Exp Neurol; 1994 Sep; 53(5):492-501. PubMed ID: 8083690 [TBL] [Abstract][Full Text] [Related]
39. Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis. Bouafia A; Golmard JL; Thuries V; Sazdovitch V; Hauw JJ; Fontaine B; Seilhean D Neuropathol Appl Neurobiol; 2014 Aug; 40(5):579-90. PubMed ID: 23659577 [TBL] [Abstract][Full Text] [Related]
40. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]